Optimizing Your Essential Commercialization Teams
|For those of you following closely (thank you!), you may recall that in an earlier e-conversation — 21st Century Commercialization — More than a Point in Time! — we defined commercialization as neither a function nor a process. Rather, we think of it as a “mindset” — something present from the very beginning of product… Read the full article…|
Where Are Decisions Made in Your Organization (And Why Does It Matter)?
|Can you draw it? At your next company lunch and learn, try this experiment: Ask ten people from different functions to take a blank piece of flip chart paper (assuming you still have flip charts!). Then ask them to draw a picture of how key decisions are made in your organization. You might even give… Read the full article…|
Reading Recommendations from the High Cs
|Summer is a wonderful time for catching up on our reading – whether business, pleasure, or something in between. This month, we sought out recommendations from leaders in our biopharma ecosystem, which is why we are calling today’s e-conversation,“Reading Recommendations from the High Cs” (C-Suite, VCs, and Commercial Leaders in Biopharma).We asked for book recommendations across the… Read the full article…|
Are Your Assumptions Serving You Well?
|Ah, June, the season of life transitions — weddings, graduations, school progression and, with the year nearly half over, a reminder to reflect on where we have been and where we are going in 2019.I had such an opportunity, recently, as I listened to the commencement speakers at my son, Jonathan’s, college graduation (empty nest, here we come).… Read the full article…|
The Future Is Now
|Back in the early 2000s, I was head of commercial strategy at Millennium Pharmaceuticals in Cambridge, Massachusetts. I remember saying to then CEO, Mark Levin, that we had an opportunity to define how the company vision, “Transcend the Limits of Medicine,”could be translated at the customer level. This was a once-in-a-career role. I was able to surround… Read the full article…|
Courage to Call It Out!
|I began my career in the early 1980s as a pharmaceutical sales rep. It was a crazy time, when national sales meetings were more like spring break and none of today’s corporate norms were even contemplated, let alone in place. Yes, there was bad behavior, and no, it was not often addressed. It was just part… Read the full article…|
Living in a Parallel Universe
|Launching a company and drug simultaneously. (What follows is a synopsis of a recent “team development call,” something that occurs at The NemetzGroup over Zoom every other week. During these calls, we select a topic that allows us to enhance our learning, share best practices, and improve our client offerings.) We began by stating the… Read the full article…|
Tales from the Community… Our Readers Speak!
|This e-conversation goes out to about 2,000 people from the industry, our team’s network, and my life. (Thank you LinkedIn.) Over the course of publishing, we have heard from many of you on a broad range of topics. What we have found fascinating is that different topics generate interest with different people (welcome to the… Read the full article…|
Tales from the Healthcare Front Lines
|Each month, you have given our team permission to communicate our views on the biopharma industry, its leadership, and overall commercialization of innovative medicines. We share this perspective with knowledge of a healthcare system based on what we read, hear, and know from personal experience. In our industry, we often talk about innovation, technology, data,… Read the full article…|
Designing Effective Physician Advisory Board Meetings
|Physician advisory board meetings are quite common in our industry — and, done well, they can be very helpful. Convening a face-to-face meeting with a group of expert physicians in a given therapeutic area benefits biopharma companies in several ways. Some of these include: verifying assumptions about unmet medical needs in the market; gaining insight… Read the full article…|